ACVR2B and cancer: In fact, the degree of atrophy in skeletal and cardiac muscle demonstrated by this ligand is very reminiscent of that found in a severe murine model of cancer cachexia, which is ameliorated by anti‐ActRIIB treatment (Zhou et al, 2010).